Cargando…

Impact of sodium–glucose cotransporter 2 inhibitors on blood pressure

SGLT2 inhibitors are glucose-lowering agents used to treat type 2 diabetes mellitus (T2DM). These agents target the kidney to promote urinary glucose excretion, resulting in improved blood glucose control. SGLT2-inhibitor therapy is also associated with weight loss and blood pressure (BP) lowering....

Descripción completa

Detalles Bibliográficos
Autor principal: Reed, James W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089867/
https://www.ncbi.nlm.nih.gov/pubmed/27822054
http://dx.doi.org/10.2147/VHRM.S111991